Candriam S.C.A. Merck & Co., Inc. Transaction History
Candriam S.C.A.
- $16.9 Billion
- Q4 2024
A detailed history of Candriam S.C.A. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 2,217,423 shares of MRK stock, worth $194 Million. This represents 1.3% of its overall portfolio holdings.
Number of Shares
2,217,423
Previous 2,465,714
10.07%
Holding current value
$194 Million
Previous $280 Million
21.22%
% of portfolio
1.3%
Previous 1.64%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,953Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$22 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.6 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.08 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.36 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $222B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...